Miglitol Pregnancy and Breastfeeding Warnings
Miglitol is also known as: Glyset
Miglitol Pregnancy Warnings
FDA pregnancy category: B Use of miglitol is not recommended unless clearly needed.
Fetotoxicity was indicated by a slight but significant reduction in fetal weight in rats given 450 mg/kg, and a slight reduction in fetal weight, delayed ossification of the fetal skeleton, and an increase in the percentage of nonviable fetuses in rabbits given 200 mg/kg (12 and 10 times the maximum recommended human dose based on body surface area, respectively). These studies revealed no evidence of fetal malformations. There are no controlled data in human pregnancy. FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
Miglitol Breastfeeding Warnings
Following a 100 mg maternal dose, total excretion into milk accounted for 0.02% with an estimated exposure of 0.4% of the maternal dose to the nursing infant.
Use of miglitol is not recommended. Excreted into human milk: Yes Excreted into animal milk: Unknown The effects in the nursing infant are unknown.
See Also...
- Miglitol use while Breastfeeding (in more detail)
- miglitol Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
